Synonyms: compound I [WO2022042577A1]
Compound class:
Synthetic organic
Comment: This is the chemical structure for the INN pumecitinib. The structure is claimed as a Janus kinase (JAK) inhibitor in patent WO2022042577A1 [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
2-[3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-1-propan-2-ylsulfonylazetidin-3-yl]acetonitrile |
International Nonproprietary Names ![]() |
|
INN number | INN |
12427 | pumecitinib |
Synonyms ![]() |
compound I [WO2022042577A1] |
Database Links ![]() |
|
CAS Registry No. | 2401057-12-1 (source: WHO INN record) |
GtoPdb PubChem SID | 479821165 |
PubChem CID | 141761076 |
Search Google for chemical match using the InChIKey | OUXYFMCMGWQWQF-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | OUXYFMCMGWQWQF |
Search PubMed clinical trials | pumecitinib |
Search PubMed titles | pumecitinib |
Search PubMed titles/abstracts | pumecitinib |
UniChem Compound Search for chemical match using the InChIKey | OUXYFMCMGWQWQF-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | OUXYFMCMGWQWQF-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Pumecitinib (links to external site)
Cat. No. HY-148791 |